# Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension

> **NCT05049096** · NA · TERMINATED · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 103 (actual)

## Conditions studied

- Hypertension
- Blood Pressure
- Cardiovascular Diseases

## Interventions

- **DEVICE:** focused power ultrasound mediate inferior perirenal adipose tussue modification
- **DEVICE:** sham-control group

## Key facts

- **NCT ID:** NCT05049096
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-01
- **Primary completion:** 2023-11-20
- **Final completion:** 2023-11-20
- **Target enrollment:** 103 (ACTUAL)
- **Why stopped:** Till interim analysis, 100 cases were enrolled, 71 of which during the COVID-19. Affected by epidemic control policy, 58 cases had examination window exceeded or missed, causing significant impact on endpoints, so we decided to terminate the trial.
- **Last updated:** 2023-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05049096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05049096, "Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05049096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*